Updates in the Management of Relapsed and Refractory Acute Lymphoblastic Leukemia: An Urgent Plea for New Treatments Is Being Answered!

DuVall, Adam S; Sheade, Jori; Anderson, Daniela; Yates, Samuel J; Stock, Wendy

DuVall, Adam S; Sheade, Jori; Anderson, Daniela; Yates, Samuel J; Stock, Wendy.

Afiliación

DuVall AS; University of Chicago Biological Sciences Division, Department of Medicine, Section of Hematology Oncology, Chicago, IL.
Sheade J; University of Chicago Biological Sciences Division, Department of Medicine, Chicago, IL.
Anderson D; University of Chicago Biological Sciences Division, Department of Medicine, Chicago, IL.
Yates SJ; University of Chicago Biological Sciences Division, Department of Medicine, Chicago, IL.
Stock W; University of Chicago Biological Sciences Division, Department of Medicine, Section of Hematology Oncology, Chicago, IL.

JCO Oncol Pract ; 18(7): 479-487, 2022 07.

Article en En | MEDLINE | ID: mdl-35380890

Asunto(s)

Leucemia-Linfoma Linfoblástico de Células Precursoras; Enfermedad Aguda; Humanos; Leucemia-Linfoma Linfoblástico de Células Precursoras/complicaciones; Leucemia-Linfoma Linfoblástico de Células Precursoras/terapia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras Límite: Humans Idioma: En Revista: JCO Oncol Pract Año: 2022 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google